Jim and Jeff discuss this pharmaceutical stock's drug trials. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake

CNBC Investing Club Disclaimer

Wrapping up a volatile holiday-shortened trading week, Carl Quintanilla, Jim Cramer and David Faber delved into two big movers: UnitedHealth plunging and dragging the Dow into sell-off mode after posting an earnings miss and slashing guidance due to higher medical care costs. A different story for Eli Lilly -- shares surging in reaction to late-stage trial results involving its experimental obesity pill. The anchors reacted to President Trump's Truth Social post blasting Jerome Powell -- it says the Fed chair's "termination cannot come fast enough." Also in focus: Nvidia CEO Jensen Huang visits China and Taiwan Semiconductor beats on earnings after Wednesday's chip sector sell-off, "Faber Report on" Global Payments' $22.7 billion acquisition.

Squawk on the Street Disclaimer

Stocks across the board kicking off Wednesday in the red as Nvidia and the chips drag Tech lower – Carl Quintanilla, David Faber, and Leslie Picker broke down the latest for stocks on a busy morning of earnings and DC headlines, along with fresh data top of the hour. What it all means for stocks like Nvidia and AMD – as both warn of big costs tied Trump’s new curb on chips going to China… Plus: Citi’s U.S. Equity Strategist joined the team with his take on things – fresh off lowering his estimates for the S&P.

Also in focus: United Airlines reporting results – what their CEO is saying about the consumer; A look at whether better-than-feared Retail Sales could be the calm before the storm; The numbers behind a historic boom in 0-day options; And a live read from outside the courtroom as the FTC’s antitrust case against Meta continues for a 3rd day

Squawk on the Street Disclaimer

Carl Quintanilla, Jim Cramer and David Faber led off the show by exploring the tech sector under pressure, especially the chips. Shares of Nvidia and AMD down sharply after both companies said they would take charges related to new U.S. curbs on chip exports to China. What should investors do with Nvidia and other semiconductor stocks? Also in focus: The state of the U.S.-China trade war, March retail sales beat, Mark Zuckerberg and the FTC-Meta trial, United Airlines and other earnings winners bucking the market downtrend.

Squawk on the Street Disclaimer

Another day of gains on the S&P, Dow, and Nasdaq: all in the green for the first hour of trade… David Faber, Carl Quintanilla, and Sara Eisen broke down the latest for stocks on a busy morning of headlines and reports. Why the head of investing for Morgan Stanley’s Wealth Management division says U.S. equities are worth holding onto – and a deep dive into 3 tariff headlines: China reportedly halting Boeing deliveries as trade tensions intensify, Trump’s new investigation into pharmaceutical imports (and potential road to new tariffs on the industry), and LVMH’s consumer concerns – as they warn of a “disrupted geopolitical and economic environment”.

Also this hour: a wide-ranging interview with Bank of America Chairman & CEO Brian Moynihan, fresh off quarterly results there… Key Topics? Markets, Bonds, Consumer Trends, and more.

Squawk on the Street Disclaimer

With the major indices aiming for a third consecutive day of gains, Carl Quintanilla, Jim Cramer and David Faber reacted to a new survey that shows investors haven't been this bearish about growth in 30 years. Tariffs and the trade war also in the spotlight: President Trump setting the stage for tariffs on chips and pharmaceuticals, China reportedly orders its airlines not to accept deliveries of Boeing jets. Also in focus: Bank of America and Citi post earnings beats, what Johnson & Johnson's CFO told CNBC about pharma tariffs, Netflix's $1 trillion goal, luxury pain for LVMH, activism lifts HPE shares.

Squawk on the Street Disclaimer

Jim and Jeff explain the tariff exemptions' impact on this mega cap tech stock. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake

CNBC Investing Club Disclaimer